Cardiac structure and function in a mouse model of uraemia without hypertension

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue 7, 2008, Pages 660-666

  Bro, Susanne ^a,b   Bollano, Entela ^c   Bruel, Annemarie ^d   Olgaard, Klaus ^a   Nielsen, Lars B ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Animals; Blood pressure; Disease models; Echocardiography; Gene expression; Kidney failure

Indexed keywords

APOLIPOPROTEIN E; BIGLYCAN; CREATININE; ENALAPRIL MALEATE; HEMOGLOBIN; MESSENGER RNA; PROCOLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLE; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART WEIGHT; HEMOGLOBIN BLOOD LEVEL; HYPERLIPOPROTEINEMIA TYPE 3; HYPERTENSION; KIDNEY TUMOR; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHAM PROCEDURE; SYSTOLE; SYSTOLIC BLOOD PRESSURE; UREMIA;

ANIMALS; APOLIPOPROTEINS E; DISEASE MODELS, ANIMAL; ENALAPRIL; FIBROSIS; HEART; HYPERTENSION; KIDNEY; MALE; MICE; MYOCARDIUM; NEPHRECTOMY; PEPTIDYL-DIPEPTIDASE A; UREMIA;

ANIMALIA; MUS;

EID: 55249103198     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510802037272     Document Type: Article

References (38)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
2. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005;16:489-95.
3. United States Renal Data System (USRDS), Annual Data Report 2004. Available at: www.usrds.org.
4. Tyralla K, Amann K. Morphology of the heart and arteries in renal failure. Kidney Int 2003;63 Suppl 84:S80-3.
5. Stefanski A, Schmidt KG, Waldherr R, Ritz E. Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis. Kidney Int 1996;50:1321-6.
6. Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, et al. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 2004;65:1461-6.
7. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996;27:347-54.
8. Amann K, Wanner C, Ritz E. Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrol 2006;17:2112-19.
9. Amann K, Breitbach M, Ritz E, Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998;9:1018-22.
10. Perneger TV, Whelton PK, Klag MJ. History of hypertension in patients treated for end-stage renal disease. J Hypertens 1997;15:451-6.
11. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 2005;16:2778-88.
12. Bro S, Bentzon JF, Falk E, Andersen CB, Olgaard K, Nielsen LB. Chronic renal failure accelerates atherogenesis in apolipoprotein e-deficient mice. J Am Soc Nephrol 2003;14:2466-74.
13. Buzello M, Tornig J, Faulhaber J, Ehmke H, Ritz E, Amann K. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol 2003;14:311-16.
14. Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 2005;16:109-16.
15. Bro S, Moeller F, Andersen CB, Olgaard K, Nielsen LB. Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice. J Am Soc Nephrol 2004;15:1495-503.
16. Bro S, Borup R, Andersen CB, Moeller F, Olgaard K, Nielsen LB. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006;26:570-5.
17. Bro S, Binder CJ, Witztum JL, Olgaard K, Nielsen LB. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007;27:1080-6.
18. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994;90:2786-96.
19. Krege JH, Hodgin JB, Hagaman JR, Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 1995;25:1111-15.
20. Bollano E. Sahlgrenska Academy, Goteborg University, Sweden [Doctoral Thesis]. 2001.
21. Nielsen LB, Bartels ED, Bollano E. Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem 2002;277:27014-20.
22. Puchtler H, Waldrop FS, Valentine LS. Polarization microscopic studies of connective tissue stained with picro-sirius red FBA. Beitr Pathol 1973;150:174-87.
23. Ma LJ, Fogo AB. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int 2003;64:350-5.
24. Kren S, Hostetter TH. The course of the remnant kidney model in mice. Kidney Int 1999;56:333-7.
25. Kennedy DJ, Elkareh J, Shidyak A, Shapiro AP, Smaili S, Mutgi K, et al. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am J Physiol Renal Physiol 2008;294:F450-4.
26. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, et al. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 2006;47:488-95.
27. Rambausek M, Ritz E, Mall G, Mehls O, Katus H. Myocardial hypertrophy in rats with renal insufficiency. Kidney Int 1985;28:775-82.
28. Litwin SE, Katz SE, Morgan JP, Douglas PS. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994;89:345-54.
29. Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, et al. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 1996;94:1109-17.
30. Pollick C, Hale SL, Kloner RA. Echocardiographic and cardiac Doppler assessment of mice. J Am Soc Echocardiogr 1995;8:602-10.
31. Manning WJ, Wei JY, Katz SE, Litwin SE, Douglas PS. In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am J Physiol 1994;266:H1672-5.
32. Collins KA, Korcarz CE, Lang RM. Use of echocardiography for the phenotypic assessment of genetically altered mice. Physiol Genomics 2003;13:227-39.
33. Christoffersen C, Bollano E, Lindegaard ML, Bartels ED, Goetze JP, Andersen CB, et al. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 2003;144:3483-90.
34. Dhein S, Rohnert P, Markau S, Kotchi-Kotchi E, Becker K, Poller U, et al. Cardiac beta-adrenoceptors in chronic uremia: studies in humans and rats. J Am Coll Cardiol 2000;36:608-17.
35. Rostand SG, Drueke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999;56:383-92.
36. Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 2004;116:263-72.
37. Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res 1999;43:838-49.
38. Gonzalez BL, Kurnjek ML, Muller A, Basso N. Effect of chronic angiotensin II inhibition on the cardiovascular system of the normal rat. Am J Hypertens 2000;13:1301-7.